Hopeful law firms in search of plaintiffs for kickback suits against Sanofi

Sanofi ($SNY) made its fair share of bad headlines in the latter half of 2014, and law firms are hoping that means one thing: plaintiffs for shareholder lawsuits against the French drugmaker. Potential claims focus on an alleged illegal kickback strategy for the company's diabetes franchise, designed to boost sales. More

Suggested Articles

Former Indivior CEO Shaun Thaxter will face six months in federal prison for his role in misleading government officials on the dangers of Suboxone.

As of Friday after local time, 36 people have died in Korea after getting flu shots provided by at least seven companies, including Sanofi.

Two prominent pneumococcal vaccines from Merck and Pfizer are running low in Europe in a possible ill omen for the coming winter: report.